In a 68-patient Phase 2 clinical trial , Ocular Therapeutix's (NASDAQ: OCUL ) Sustained Release Dexamethasone (OTX-DP) achieves one efficacy endpoint of statistically significant lower ocular itching and conjunctival redness scores versus placebo on days 14, 28 and 42 after insertion of the punc
canaliculus与发音含义,同义词,反义词,翻译,刑和更多的